全球电子产品市场规模、份额和成长分析：按产品、类型、应用和地区 - 产业预测（2024-2031）

2022年，全球电子药品市场规模为239亿美元，从2023年的255.7亿美元成长到2031年的439.4亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。 。

由于医疗技术的进步、研发成本的增加、人口老化和慢性病盛行率的上升，电子产品市场预计将大幅成长。由于患者倾向于侵入性较小的治疗，与植入式设备相比，预计非侵入性设备的需求将会很大。然而，严格的法律规范、频繁的产品召回、漫长的核准流程和高成本等挑战可能会阻碍市场潜力。全球心血管疾病的增加预计将进一步推动市场扩张，特别是在电子药物用于治疗这些疾病方面。各国政府已开始提供资金以加强研发工作，这表明支持性环境可以在未来四年内显着扩大市场机会。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境

电子药品市场规模：依产品分类，复合年增长率（2024-2031）

• 市场概况
• 心臟心律调节器和植入式心臟整流去颤器
• 人工电子耳
• 神经调节
  • 脊髓刺激设备
  • 深层脑部刺激器
  • 迷走神经刺激设备
  • 荐骨神经刺激器
  • 胃电刺激设备
  • 经皮神经刺激设备
  • 经颅磁刺激器
  • 呼吸电刺激设备
  • 三叉神经刺激设备
  • 反应性神经刺激设备
• 视网膜植入

电子药品市场规模：依类型，复合年增长率（2024-2031）

• 市场概况
• 植入式电医疗装置
• 非侵入性电疗设备

电子药品市场规模：依应用划分，复合年增长率（2024-2031）

• 市场概况
• 心臟心律调节器和植入式心臟整流去颤器(ICD)
  • 心律不整
  • 心臟衰竭
  • 其他心臟心律调节器和 ICD 应用
• 脊髓刺激设备
  • 慢性疼痛
  • 背部手术失败综合症
  • 缺血
  • 帕金森氏症
  • 发抖
  • 忧郁症
  • 其他星展银行应用程式
  • 尿失禁
  • 大便失禁
  • 癫痫
  • 其他 VNS 应用
  • 胃轻瘫
  • 肥胖
  • 抗治疗性忧郁症
  • 其他 TENS 应用
  • 偏头痛
  • 脊髓损伤
  • 注意力不足/过动症

电子保健品市场规模，复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Medtronic
• Boston scientific corporation
• Abbott
• Livanova plc
• Cochlear ltd.
• Microport scientific corporation
• Sonova
• Nevro corp.
• Axonics, Inc.
• Neuronetics
• Electrocore, Inc.
• Neuropace, Inc.
• Biotronik
• Medico SRL
• Zhejiang nurotron biotechnology co., ltd.
• Med-EL
• Aleva neurotherapeutics
• Neurosigma, inc.
• Biowave corporation
• Soterix medical Inc

结论和建议

Global Electroceuticals Market size was valued at USD 23.9 billion in 2022 and is poised to grow from USD 25.57 billion in 2023 to USD 43.94 billion by 2031, growing at a CAGR of 7.0% during the forecast period (2024-2031).

The electroceuticals market is poised for significant growth, driven by advancements in medical technology, increasing research and development spending, an aging population, and a rising prevalence of chronic diseases. Non-invasive devices are expected to see higher demand compared to implantable options as patients lean towards less invasive treatments. However, challenges such as stringent regulatory frameworks, frequent product recalls, lengthy approval processes, and high costs may hinder market potential. The global rise in cardiovascular diseases will further fuel market expansion, particularly in the utilization of electroceuticals for these conditions. Governments are initiating funding to bolster R&D efforts, indicating a supportive environment that could significantly enhance market opportunities over the next four years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electroceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electroceuticals Market Segmental Analysis

Global Electroceuticals Market is segmented by product, type, application and region. Based on product, the market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, cochlear implants, neuromodulators and retinal implants. Based on type, the market is segmented into implantable electroceutical devices and noninvasive electroceutical devices. Based on application, the market is segmented into cardiac pacemakers & implantable cardioverter defibrillators (ICD) and spinal cord stimulators. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electroceuticals Market

A key driver of growth in the global electroceuticals market is the increasing incidence of cardiovascular diseases, which are among the leading causes of mortality worldwide. The World Health Organization reports that these diseases result in over 17.3 million deaths annually, with projections suggesting this number may rise to 23.6 million by 2030. Cardiovascular diseases affect approximately 31% of the global population, disproportionately impacting low and middle-income countries, where they account for 80% of fatalities. In the United States alone, over 800,000 deaths attributed to cardiovascular conditions were reported, illustrating a significant opportunity for expansion within the electroceuticals sector. Additionally, innovations and new product launches by key market players further propel market growth in the foreseeable future.

Restraints in the Global Electroceuticals Market

One significant constraint on the Global Electroceuticals market is the limited awareness of electroceutical devices among populations in low and middle-income countries (LMIC). Although high-income nations have successfully adopted a variety of implantable devices, including those for cardiac rhythm management, access remains scarce in LMIC. Research from the American Heart Association indicates that many Latin Americans in the United States are unfamiliar with automated external defibrillators (AEDs) and their operation. This lack of public knowledge is detrimental because it hampers potential survival rates following cardiac arrests, as individuals might not receive essential defibrillation treatment in critical situations.

Market Trends of the Global Electroceuticals Market

The global electroceuticals market is experiencing significant growth, fueled by increased investment from numerous key players such as Medtronic, Boston Scientific, and Abbott Laboratories. This escalating trend is driven by the expanding product portfolios and innovative therapies that address various diseases, alongside strategic initiatives like mergers, acquisitions, and technological advancements. Recent FDA approvals, including Medtronic's Intellis Platform and Boston Scientific's Vercise Genus system, illustrate the rapid development in this sector. As the industry embraces advanced technologies and collaborative efforts, the market is poised for robust expansion, catering to the increasing demand for minimally invasive therapeutic options worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Electroceuticals Market Size by Product & CAGR (2024-2031)

• Market Overview
• Cardiac Pacemakers & Implantable Cardioverter Defibrillators
• Cochlear Implants
• Neuromodulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Vagus Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Electrical Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Transcranial Magnetic Stimulators
  • Respiratory Electrical Stimulators
  • Trigeminal Nerve Stimulators
  • Responsive Neurostimulators
• Retinal Implants

Global Electroceuticals Market Size by Type & CAGR (2024-2031)

• Market Overview
• Implantable Electroceutical Devices
• Noninvasive Electroceutical Devices

Global Electroceuticals Market Size by Application & CAGR (2024-2031)

• Market Overview
• Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICD)
  • Arrhythmia
  • Heart Failure
  • Other Cardiac Pacemaker & Icd Applications
• Spinal Cord Stimulators
  • Chronic Pain
  • Failed Back Surgery Syndrome
  • Ischemia
  • Parkinson'S Disease
  • Tremors
  • Depression
  • Other Dbs Applications
  • Urine Incontinence
  • Fecal Incontinence
  • Epilepsy
  • Other Vns Applications
  • Gastroparesis
  • Obesity
  • Treatment-Resistant Depression
  • Other Tens Applications
  • Migraine
  • Spinal Cord Injury
  • Attention-Deficit/Hyperactivity Disorder

Global Electroceuticals Market Size & CAGR (2024-2031)

• North America (Product, Type, Application)
  • USA
  • Canada
• Europe (Product, Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston scientific corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livanova plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microport scientific corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Electrocore, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuropace, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medico S.R.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang nurotron biotechnology co., ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Med-EL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva neurotherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurosigma, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biowave corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations